AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. AbSci’s technology enables dramatic reductions in the cost of producing novel and existing biologics, acceleration of drug discovery timelines, and increased efficiency and flexibility throughout the manufacturing process.
Posts Mentioning This Company
AbSci’s Integrated Drug Creation™ Platform
AbSci’s revolutionary synthetic biology platform technology offers fully-integrated, AI-assisted, de novo drug discovery and cell line development … in weeks
No pipelines published yet
No services posted yet